Table 2.
All patients N = 309 | Patients without MACE N = 267 | Patients with MACE N = 42 | *P-value | |
---|---|---|---|---|
CSBF at rest (mL/min) | 91.8 ± 37.6 | 87.2 ± 33.5 | 121.2 ± 47.9 | < 0.001 |
CSBF during ATP infusion (mL/min) | 234.4 ± 81.1** | 230.3 ± 80.8** | 237.8 ± 83.9** | 0.58 |
ΔCSBF (mL/min) | 139.5 ± 66.5 | 143.1 ± 67.7 | 116.5 ± 52.6 | 0.016 |
Coronary flow reserve | 2.7 ± 0.9 | 2.8 ± 0.9 | 2.0 ± 0.4 | < 0.001 |
Coronary flow reserve < 2.0 | 55 (17%) | 30 (11%) | 25 (60%) | < 0.001 |
Data are expressed as mean ± standard deviation or number (%)
* P-values represent the difference between patients with and without MACE. ** P < 0.05 vs. CSBF at rest
ΔCSBF = CSBF during ATP infusion – CSBF at rest
Coronary flow reserve = CSBF during ATP infusion / CSBF at rest × 100
ATP adenosine triphosphate, CSBF coronary sinus blood flow, MACE major adverse cardiac events